Mark David Pedigo, PA-C

Mark Pedigo practices at Texas Health Physicians Group in Euless, Texas.

Mark Pedigo's NPI, 1144798570, was assigned on November 3, 2018. Mark Pedigo holds Texas license PA12314.

Mark Pedigo's primary practice is Texas Health Physicians Group, at 251 Westpark Way, Euless, TX 76040 in Tarrant County. The practice phone is (214) 860-6300.

Mark Pedigo's primary practice is Texas Health Physicians Group in Euless, Texas. Mark Pedigo is also affiliated with Medical City Denton. The medical group on file is Texas Health Physicians Group. Dmand AI also links Mark Pedigo to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Pedigo practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Mark Pedigo's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Mark Pedigo is licensed in Texas.

Dmand AI lists acute sinusitis, acute skin infection, ADHD, anxiety, asthma, benign or precancerous skin growths, bladder disease and bronchitis among the conditions Mark Pedigo treats.

CMS data shows 1,005 Medicare services from Mark Pedigo across 13 procedure codes in 2024, for 294 Medicare patients. Medicare paid $50,012 for them. Every service was in an office.

CMS counts 294 Medicare patients who saw Mark Pedigo in 2024. The largest group is 65 to 74, with 127 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mark Pedigo's median patient age at 58, with 39% women.

In 2024, Mark Pedigo wrote 5,079 Medicare Part D claims for 642 patients. 83% of them were for generic drugs. CMS names the drug for 4,175 of them, across 111 drugs with 11 or more claims each, at $444,935 in total drug cost.

Mark Pedigo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mark Pedigo as offering telehealth.

CMS Open Payments shows 310 general payments to Mark Pedigo from 44 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $521.